- Home
- YORW vs LXRX Comparison
YORW vs LXRX Comparison
Compare YORW & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YORW
- LXRX
- Stock Information
- Founded
- YORW 1816
- LXRX 1995
- Country
- YORW United States
- LXRX United States
- Employees
- YORW N/A
- LXRX N/A
- Industry
- YORW Water Supply
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- YORW Utilities
- LXRX Health Care
- Exchange
- YORW Nasdaq
- LXRX Nasdaq
- Market Cap
- YORW 445.3M
- LXRX 428.8M
- IPO Year
- YORW N/A
- LXRX 2000
- Fundamental
- Price
- YORW $30.43
- LXRX $1.08
- Analyst Decision
- YORW
- LXRX Buy
- Analyst Count
- YORW 0
- LXRX 5
- Target Price
- YORW N/A
- LXRX $3.23
- AVG Volume (30 Days)
- YORW 122.5K
- LXRX 1.8M
- Earning Date
- YORW 11-06-2025
- LXRX 08-06-2025
- Dividend Yield
- YORW 2.88%
- LXRX N/A
- EPS Growth
- YORW N/A
- LXRX N/A
- EPS
- YORW 1.37
- LXRX N/A
- Revenue
- YORW $76,236,000.00
- LXRX $58,432,000.00
- Revenue This Year
- YORW $7.50
- LXRX N/A
- Revenue Next Year
- YORW $6.33
- LXRX N/A
- P/E Ratio
- YORW $22.22
- LXRX N/A
- Revenue Growth
- YORW 4.09
- LXRX 1504.83
- 52 Week Low
- YORW $29.86
- LXRX $0.28
- 52 Week High
- YORW $39.79
- LXRX $2.18
- Technical
- Relative Strength Index (RSI)
- YORW 43.98
- LXRX 46.84
- Support Level
- YORW $30.00
- LXRX $1.03
- Resistance Level
- YORW $31.10
- LXRX $1.11
- Average True Range (ATR)
- YORW 0.58
- LXRX 0.06
- MACD
- YORW -0.04
- LXRX -0.01
- Stochastic Oscillator
- YORW 23.37
- LXRX 25.00
About YORW York Water Company (The)
The York Water Co is an investor-owned water utility company in the United States. The primary business of the company is to impound, purify to meet or exceed safe drinking water standards and distribute water. It also owns and operates three wastewater collection systems and eleven wastewater collection and treatment systems. The company operates within its franchised territory, which covers more than 57 municipalities within four counties in south-central Pennsylvania.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.